Skip to main content
SpringerLink
Log in

Experimental validation for the use of recombinant prourokinase and its immobilized forms in the treatment of postoperative fibrinoid syndrome in ophthalmology

  • Experimental Methods for Clinical Practice
  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

Abstract

The specific therapeutic effectiveness of a single intravitreal injection of native and immobilized recombinant prourokinase is assessed in lensvitrectomized rabbits with the fibrinoid syndrome. The agents almost completely lyse the fibrin clot within 1–8 h. Heteroprotein conjugates of protein kinase with molecular weight of 900 kD and high fibrinolytic activity at 2–20-fold lower doses of the enzyme are preferable. Native and immobilized prourokinase are recommended for clinical use in case of intraocular fibrin formation after lensvitrectomy and other operations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. V. F. Danilichev, S. V. Kol’tsova, and E. V. Boiko,Oftal’mol. Zh., No. 5–6, 303–307 (1993).

  2. V. F. Danilichev and I. B. Maksimov,Ocular Injuries and Diseases: Use of Enzymes and Peptide Bioregulators [in Russian], Minsk (1994).

  3. L. V. Zobina and A. D. Romashchenko,Vestn. Oftal’mol.,103, No. 1, 51–57 (1987).

    CAS  Google Scholar 

  4. G. P. Kleking and I. N. Bokarev,Klin. Med.,68, No. 6, 13–19 (1990).

    CAS  Google Scholar 

  5. S. V. Kol’tsova,Bioorgan. Khimiya,21, No. 6, 408–420 (1995).

    CAS  Google Scholar 

  6. S. V. Kol’tsova, E. V. Boiko, N. P. Kuznetsova, and V. F. Danilichev,Vopr. Med. Khimii,41, No. 3, 13–17 (1995).

    PubMed  CAS  Google Scholar 

  7. N. P. Kuznetsova, R. N. Mishaeva, S. V. Kol’tsova,et al., Bioorgan. Khimiya,19, No. 7, 871–879 (1993).

    CAS  Google Scholar 

  8. E. V. Chazov, R. A. Gundorova, A. D. Romashchenko,et al.,Vestn. Oftal’mol., No. 4, 61–64 (1982).

  9. G. J. Jaffe, G. A. Abrams, G. A. Williams, and D. P. Han,Ophthalmology,97, 184–189 (1990).

    PubMed  CAS  Google Scholar 

  10. M. J. Poznansky,Methods Enzymol,137, Pt. D., 566–574 (1988).

    PubMed  CAS  Google Scholar 

  11. K. Schmitz, J.-H. Greite, and E. M. Bartenschlager,Germ. J. Ophthalmol.,4, 75–79 (1995).

    CAS  Google Scholar 

  12. V. P. Torchilin, A. V. Maksimenko, and A. V. Mazaev,Methods Enzymol.,137, Pt. D., 552–566 (1988).

    Article  PubMed  CAS  Google Scholar 

  13. M. Verstraete and D. Collen,Blood,67, 1529–1541 (1986).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Military Medical Academy, USSR

    E. V. Boiko, V. F. Danilichev & S. V. Kol’tsova

  2. Institute of High-Molecular-Weight Compounds, Russian Academy of Sciences, St. Petersburg

    E. V. Boiko, V. F. Danilichev & S. V. Kol’tsova

Authors
  1. E. V. Boiko
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. V. F. Danilichev
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. V. Kol’tsova
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Translated fromByulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 123, No. 2, pp. 201–204, February, 1997

Rights and permissions

Reprints and permissions

About this article

Cite this article

Boiko, E.V., Danilichev, V.F. & Kol’tsova, S.V. Experimental validation for the use of recombinant prourokinase and its immobilized forms in the treatment of postoperative fibrinoid syndrome in ophthalmology. Bull Exp Biol Med 123, 174–177 (1997). https://doi.org/10.1007/BF02766444

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02766444

Key Words

Search

Navigation